Summary
Updated Aug 30, 2026
Marshman Fund Trust II is 10% Owner of Harmony Biosciences Holdings, Inc. (HRMY). 1 SEC Form 4 filing on record, dated 5 November 2024. Most recent open-market trade: sold $18.18M of HRMY on 5 November 2024. Lifetime open-market sales: $139.39M.
Recent Transactions
2Every recent SEC Form 4 transaction Marshman Fund Trust II has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Marshman Fund Trust II files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sandip Kapadia - $1.01M of HRMY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Marshman Fund Trust II?
Marshman Fund Trust II is a trust, tracked as 10% Owner of Harmony Biosciences Holdings, Inc. (HRMY). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Marshman Fund Trust II last file a Form 4?
The only primary Form 4 on record is dated 5 November 2024.
Has Marshman Fund Trust II been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($139.39M) across all tracked filings.
Where can I see all of Marshman Fund Trust II's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Marshman Fund Trust II and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
